Invasive mold infections (IMIs) are an important cause of morbidity and mor
tality in patients who are undergoing bone marrow transplantation (BMT). To
examine the epidemiology, risk factors, and outcome of IMIs in allogeneic
BMT recipients, all cases of mold infection among 94 adult patients who und
erwent allogeneic BMT at this institution from 1 January 1997 through 31 De
cember 1998 were reviewed retrospectively. Fifteen cases of IMI were identi
fied; infection occurred a median of 102 days after BMT. Aspergillus specie
s was the most common cause of disease, and species other than Aspergillus
fumigatus were present in 53% of patients. By multivariate analysis, the va
riable associated with infection risk was systemic glucocorticosteroid use.
Prophylactic antifungal therapy that was targeted to high-risk patients ha
d little effect on disease incidence. These observations suggest that early
identification of high-risk patients and better approaches to prevention s
hould be explored, to reduce incidence and severity of disease in this popu
lation.